Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Maryland, Baltimore
M.D. Anderson Cancer Center
Stanford University
Dartmouth-Hitchcock Medical Center
Cancer Research UK
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
National Institute for Tuberculosis and Lung Diseases, Poland
Guangzhou Women and Children's Medical Center
Nantong University
Roger Williams Medical Center